ESTRO PT 2018

(Victoria, Australia)

1. QA : credentialing of centers, review of treatment plans, incident reporting Incidence of wide range of equipment included . (Ex passive vs PBS)

2. Evaluate incidence of evolution of technology during the trial

2. Assess associated economic data for cost-benefit analysis

No “equipoise” if new techno provides better plans : randomized trial becomes unethical

Equipoise : equilibrium, counterbalance (risks and benefits in both arms). There is genuine uncertainty in the expert medical community over whether a treatment will be better than the other.